Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias

Xin Sun; Yan-na Zhao; Song Qian; Rui-lan Gao; Li-ming Yin; Li-pei Wang; Beng-hock Chong; Su-zhan Zhang

doi:10.1007/s11655-017-2754-8

Your Location：

Home >

Browse articles >

Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias

Updated：2021-08-27

- Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias
- Chinese Journal of Integrative Medicine Vol. 24, Issue 3, Pages: 200-206(2018)
- Affiliations：
  
  1. Department of Oncology, The Second Affiliated Hospital, Medical College of Zhejiang University,Hangzhou,China
  2. Department of Oncology, Zhejiang Provincial People’s Hospital,Hangzhou,China
  3. Institution of Hematology Research, The First Affiliated Hospital of Zhejiang Chinese Medical University,Hangzhou,China
  4. Department of Hematology, St George Sutherland Hospital,Sydney,Australia
- Author bio：
- Funds：
  
  Supported by the Science and Technology Program Project of Zhejiang Province (No. 2015C33173), and Chinese Medicine Foundation of Young Talents in Zhejiang Province (No. 2014ZQ006), Australia-China Institutional Links Research Program sponsored by the International Development Program of Education Australia (No. IDP 2-8)
- DOI：10.1007/s11655-017-2754-8
  CLC：
- Published：2018，
  
  Published Online：22 April 2017，
Scan for full text
Sun, X., Zhao, Yn., Qian, S. et al. Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias., Chin. J. Integr. Med. 24, 200–206 (2018). https://doi.org/10.1007/s11655-017-2754-8

Xin Sun, Yan-na Zhao, Song Qian, et al. Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias. [J]. Chinese Journal of Integrative Medicine 24(3):200-206(2018)
Sun, X., Zhao, Yn., Qian, S. et al. Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias., Chin. J. Integr. Med. 24, 200–206 (2018). https://doi.org/10.1007/s11655-017-2754-8 DOI：

Xin Sun, Yan-na Zhao, Song Qian, et al. Ginseng-Derived Panaxadiol Saponins Promote Hematopoiesis Recovery in Cyclophosphamide-Induced Myelosuppressive Mice: Potential Novel Treatment of Chemotherapy-Induced Cytopenias. [J]. Chinese Journal of Integrative Medicine 24(3):200-206(2018) DOI： 10.1007/s11655-017-2754-8.

摘要

To investigate the potential efficacy of panaxadiol saponins component (PDS-C)

a biologically active fraction isolated from total ginsenosides

to reverse chemotherapy-induced myelosuppression and pancytopenia caused by cyclophamide (CTX). Mice with myelosuppression induced by CTX were treated with PDS-C at a low- (20 mg/kg)

moderate- (40 mg/kg)

or high-dose (80 mg/kg) for 7 consecutive days. The level of peripheral white blood cell (WBC)

neutrophil (NEU) and platelet (PLT) were measured

the histopathology and colony formation were observed

the protein kinase and transcription factors in hematopoietic cells were determined by immunohistochemical staining and Western blot. In response to PDS-C therapy

the peripheral WBC

NEU and PLT counts of CTX-induced myelosuppressed mice were significantly increased in a dose-dependent manner. Similarly

bone marrow histopathology examination showed reversal of CTX-induced myelosuppression with increase in overall bone marrow cellularity and the number of hematopoietic cells (P<0.01). PDS-C also promoted proliferation of granulocytic and megakaryocyte progenitor cells in CTX-treated mice

as evidenced by significantly increase in colony formation units-granulocytes/monocytes and -megakaryocytes (P<0.01). The enhancement of hematopoiesis by PDS-C appears to be mediated by an intracellular signaling pathway

this was evidenced by the up-regulation of phosphorylated mitogen-activated protein kinase (p-MEK) and extracellular signal-regulated kinases (p-ERK)

and receptor tyrosine kinase (C-kit) and globin transcription factor 1 (GATA-1) in hematopoietic cells of CTX-treated mice (P<0.05). PDS-C possesses hematopoietic growth factor-like activities that promote proliferation and also possibly differentiation of hematopoietic progenitor cells in myelosuppressed mice

probably mediated by a mechanism involving MEK and ERK protein kinases

and C-kit and GATA-1 transcription factors. PDS-C may potentially be a novel treatment of myelosuppression and pancytopenia caused by chemotherapy.

Abstract

To investigate the potential efficacy of panaxadiol saponins component (PDS-C)

a biologically active fraction isolated from total ginsenosides

to reverse chemotherapy-induced myelosuppression and pancytopenia caused by cyclophamide (CTX). Mice with myelosuppression induced by CTX were treated with PDS-C at a low- (20 mg/kg)

moderate- (40 mg/kg)

or high-dose (80 mg/kg) for 7 consecutive days. The level of peripheral white blood cell (WBC)

neutrophil (NEU) and platelet (PLT) were measured

the histopathology and colony formation were observed

the protein kinase and transcription factors in hematopoietic cells were determined by immunohistochemical staining and Western blot. In response to PDS-C therapy

the peripheral WBC

NEU and PLT counts of CTX-induced myelosuppressed mice were significantly increased in a dose-dependent manner. Similarly

this was evidenced by the up-regulation of phosphorylated mitogen-activated protein kinase (p-MEK) and extracellular signal-regulated kinases (p-ERK)

probably mediated by a mechanism involving MEK and ERK protein kinases

and C-kit and GATA-1 transcription factors. PDS-C may potentially be a novel treatment of myelosuppression and pancytopenia caused by chemotherapy.

关键词

panaxadiol saponins componentGinsenosideschemotherapy-induced myelosuppressionmitogen-activated protein kinaseextracellular signal-regulated kinasereceptor tyrosine kinaseglobin transcription factor 1Chinese Medicine

Keywords

references

Newman NB, Sidhu MK, Baby R, Moss RA, Nissenblatt M J, Chen T, et al. Long-term bone marrow suppression during postoperative chemotherapy in rectal cancer patients after preoperative chemoradiation therapy. Int J Radiat Oncol Biol Phys 2016;94:1052–1060.

Feng L, Huang Q, Huang Z, Li H, Qi X, Wang Y, et al. Optimized animal model of CTX-induced bone marrow suppression. Basic Clin Pharmacol Toxicol 2016;119:428–435.

Kadri SS, Remy KE, Strich JR, Gea-Banacloche J, Leitman SF. Role of granulocyte transfusions in invasive fusariosis: systematic review and single-center experience. Transfusion 2015;55:2076–2085.

Cines DB, Gernsheimer T, Wasser J, Godeau B, Provan D, Lyons R, et al. Integrated analysis of long-term safety in patients with chronic immune thrombocytopaenia (ITP) treated with the thrombopoietin (TPO) receptor agonist romiplostim. Int J Hematol 2015;102:259–270.

Lee JI, Ha YW, Choi TW, Kim HJ, Kim SM, Jang HJ, et al. Cellular uptake of ginsenosides in Korean white ginseng and red ginseng and their apoptotic activities in human breast cancer cells. Planta Med 2011;77:133–140.

Zheng Y, Nan H, Hao M, Song C, Zhou Y, Gao Y. Antiproliferative effects of protopanaxadiol ginsenosides on human colorectal cancer cells. Biomed Rep 2013;1:555–558.

Lee DG, Jang SI, Kim YR, Yang KE, Yoon SJ, Lee ZW, et al. Anti-proliferative effects of ginsenosides extracted from mountain ginseng on lung cancer. Chin J Integr Med 2016;22:344–352.

Gao RL, Xu CL, Jin JM. Effect of total saponins of Panax ginseng on hematopoietic progenitor cells in normal human and aplastic anemia patients. Chin J Integr Tradit West Med (Chin) 1992;12:285–287,261-282.

Chen XH, Gao RL, Xu WH. Effect of ginsenosides in inducing proliferation and transcription factor of erythrocytic, granulo-monocytic and megakarocytic cell lines. Chin J Integr Tradit West Med (Chin) 2001;21:40–42.

Gao RL. Research and development of new Chinese materia medica for treatment of refractory hematopathy by establishment and application of multiple technique platforms. Chin J Integr Med 2007;13:95–97.

Jin J, Tao H, Gao R. Effect of ginsenosides on proliferation and differentiation of human CD34+ hematopoietic stem/progenitor cells. Chin J Integr Tradit West Med (Chin) 2000;20:673–676.

Kuang YM, Zhu Y, Gao RL, Hu J, Jiang ZY, Huang L, et al. Clinical study of Pai-Neng-Da Capsule in the treatment of chronic aplastic anemia. Chin J Integr Med 2016;22:124–129.

Gao RL, Chong BH. Research and development of the effective components of panaxdiol saponin as new Chinese patent medicine for treating hemocytopenia. Chin J Integr Med 2012;18:897–902.

Fang GL, Gao RL, Lin XJ, Jin JM. Effects of Ginseng panaxadiol saponin on proliferation and differentiation of human bone marrow CD34+ cells. J Exp Hematol (Chin) 2007;15:776–779.

Lin X, Yin L, Gao R, Liu Q, Xu W, Jiang X, et al. The effects of panaxadiol saponins on megakaryocytic maturation and immune function in a mouse model of immune thrombocytopenia. Exp Hematol 2015;43:364–373.

Wen WW, Sun X, Zhuang HF, Lin XJ, Zheng ZY, Gao RL, et al. Effects of panaxadiol saponins component as a new Chinese patent medicine on proliferation, differentiation and corresponding gene expression profile of megakaryocytes. Chin J Integr Med 2016;22:28–35.

Xu SF, Yu LM, Fan ZH, Wu Q, Yuan Y, Wei Y, Fang N. Improvement of ginsenoside Rg1 on hematopoietic function in cyclophosphamide-induced myelosuppression mice. Eur J Pharmacol 2012;695:7–12.

Gao RL, Chen XH, Lin XJ, Qian XD, Xu WH, Chong BH. Effects of notoginosides on proliferation and upregulation of GR nuclear transcription factor in hematopoietic cells. Acta Pharmacol Sin 2007;28:703–711.

Sun X, Gao RL, Lin XJ, Xu WH, Chen XH. Panax notoginseng saponins induced up-regulation, phosphorylation and binding activity of MEK, ERK, AKT, PI-3K protein kinases and GATA transcription factors in hematopoietic cells. Chin J Integr Med 2013;19:112–118.

Gao RL, Xu WH, Lin XJ, Chen XH, Wu CQ. Up-regulation of transcription factors GATA-1 and GATA-2 induced by Panax notoginosides in hematopoietic cells. Chin J Hematol (Chin) 2004;25:281–284.

Zhang Y, Dong C. Regulatory mechanisms of mitogen-activated kinase signaling. Cell Mol Life Sci 2007;64:2771–2789.

Lennartsson J, Ronnstrand L. Stem cell factor receptor/C-kit: from basic science to clinical implications. Physiol Rev 2012;92:1619–1649.

Millikan PD, Balamohan SM, Raskind WH, Kacena MA. Inherited thrombocytopenia due to GATA-1 mutations. Semin Thromb Hemost 2011;37:682–689.

FULL TEXT LINK

More>

Views

Downloads

CSCD

Alert me when the article has been cited

Submit

Tools

Publicity Resources

Qualitative analysis of Xinyue Capsules (心悦胶囊) by high-performance liquid chromatography: Preliminary evaluation of drug quality in a Sino-Austrian joint study

Future view and development of immunology: Exploring the immunology based on Chinese medicine and culture

Cost-effectiveness analysis of combined Chinese medicine and Western medicine for ischemic stroke patients

Objective tongue inspection on 142 liver cancer patients with damp-heat syndrome

Effect of Ermiao Recipe (二妙方) with medicinal guide Angelicae Pubescentis Radix on promoting the homing of bone marrow stem cells to treat cartilage damage in osteoarthritis rats

Related Author

No data

Related Institution

Center of Cardiology, Xiyuan Hospital, China Academy of Chinese Medical Sciences

Molecular Research in Traditional Chinese Medicine Group, Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University of Vienna

Georg-August-Universität Göttingen, Göttingen

The Key Laboratory of Geriatrics, Beijing Hospital and Beijing Institute of Geriatrics’ Ministry of Public Health

Medical Informatics Center, Peking University

Address：1 Caochang, xiyuan, Beijing, People's Republic of China Postal code：100091
Tel：010-62886827, 62877592 Fax：010-62874291
Technical support is provided by Beijing Founder electronics co., LTD 京ICP备05067934号-1 京公网安备11010802024621
It is recommended to read the content of this site in Chrome&IE9+. Please switch to extreme mode in browser 360.
Cookies We use cookies to help provide and enhance our service and tailor content. By continuing, you agree to the use of cookies.

⁰